NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

KITE and JUNO were both $10B market caps and less far along then NWBO

This has been posted here dozens of time. And it is still wrong.

Gillead bought Kite at the end of Aug '17. Yescarta already had completed it's pivotal trial had a BLA in progress. Approved mid Oct.

Celgene bought JUNO in Jan '18. JUNO's initial CAR-T flamed out, but their second gen effort completed it's pivotal and had results in late '17.